Gilead Sciences, Inc. to acquire Arcellx, Inc.
Gilead Sciences, Inc. and Arcellx, Inc. entered the Exit Mode archive.
- Buyer
- Gilead Sciences, Inc.
- Target
- Arcellx, Inc.
- Deal value
- USD 7,100,000,000
- Deal type
- going private
Deals by sector
Track the healthcare deals published in the Exit Mode archive, with sourced facts, narrative context, and founder-relevant patterns.
Healthcare deals tell founders where buyers are concentrating, how fast consolidation is moving, and what strategic acquirers or PE firms appear willing to back. This archive view is built to make that signal easier to track without mixing sourced facts and editorial opinion into the same layer.
Gilead Sciences, Inc. and Arcellx, Inc. entered the Exit Mode archive.
Gyre Therapeutics, Inc. and Cullgen Inc. entered the Exit Mode archive.
Novacyt Holdings UK Limited has agreed to acquire Southern Cross Diagnostics Pty Ltd in a strategic acquisition within the molecular diagnostics sector. The transaction…
EQT has agreed to acquire Oxford Biomedica plc, a UK-based CDMO and viral vector specialist, in a transaction announced on 25 February 2026. The specific financial terms…
Wood Violet Fertility LLC and Family Beginnings P.C. entered the Exit Mode archive.
Shorepower Technologies, Inc. and Aeternum Health LLC entered the Exit Mode archive.
Anchor Parent, LLC has agreed to acquire Enhabit, Inc. in a going private transaction valued at an undisclosed amount. The deal, announced on 22 February 2026, was execu…
GTCR has agreed to acquire ZENTIVA in a transaction announced on 19 February 2026. The deal involves the pharmaceutical sector, classified under NaceV2Sector_C_21. No fi…
Danaher Corporation has agreed to acquire Masimo Corporation in a going private transaction valued at an undisclosed sum. The deal, announced on 17 February 2026, was st…
Apimeds Pharmaceuticals US, Inc. and MindWave entered the Exit Mode archive.
Medpal AI plc has agreed to acquire Universal Pharmacy Ltd in a strategic acquisition valued at £45,000. The transaction was settled entirely in cash and relates to the…
THERMO FISHER and CLARIO entered the Exit Mode archive.
Erigen and Tempest Therapeutics, Inc. entered the Exit Mode archive.
LOV GROUP has agreed to acquire TIPICO in a transaction announced on 26 January 2026. The deal involves the sports betting and gaming sector, classified under NaceV2Sect…
BioCryst Pharmaceuticals, Inc. and Astria Therapeutics, Inc. entered the Exit Mode archive.
BLACKSTONE / TPG and HOLOGIC entered the Exit Mode archive.
Smith+Nephew has agreed to acquire Integrity Orthopaedics in a strategic acquisition within the Medical Technology sector. The transaction, valued at USD 225 million, in…
GlaxoSmithKline LLC and RAPT Therapeutics, Inc. entered the Exit Mode archive.
TriArtisan Capital Advisors (with Yadav Enterprises and Treville Capital) and Denny's, Inc. entered the Exit Mode archive.
Jardine Strategic Limited has agreed to acquire Mandarin Oriental International Limited in a strategic acquisition. The target is incorporated in Bermuda and the transac…
Merck Sharp & Dohme LLC and Cidara Therapeutics, Inc. entered the Exit Mode archive.
Sunstring Ltd has agreed to acquire the assets of A.M.S 2000 Trading Impex SRL, a diagnostics distributor based in Israel, in a transaction structured as an asset sale.…
YA II PN, LTD and JUPITER NEUROSCIENCES, INC. entered the Exit Mode archive.
Apollo Funds has agreed to acquire Club Atletico de Madrid in a transaction valued at an undisclosed sum. The deal involves the purchase of a Spanish sports activities a…
AI Technology Group Inc. and AVM Biotechnology Inc. entered the Exit Mode archive.
XOMA Royalty Corporation and Generation Bio Co. entered the Exit Mode archive.
HSI has agreed to acquire Sonnet BioTherapeutics Holdings, Inc. in a going private transaction valued at an undisclosed amount. The deal consideration consists of shares…
Lixte Biotechnology Holdings, Inc. and Liora Technologies Europe Ltd. entered the Exit Mode archive.
WARBURG PINCUS has agreed to acquire SEBIA in a transaction announced on 12 November 2025. The deal involves a company operating across multiple industrial sectors, incl…
CAPVEST has agreed to acquire STADA GROUP in a transaction announced on 11 November 2025. The deal involves a company operating within the pharmaceutical manufacturing s…
More M&A Tools
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Keep browsing